Director of Corporate Affairs - Media Relations

Thousand Oaks, CA, US
Jun 12, 2019
Required Education
Bachelors Degree
Position Type
Full time
Amgen is seeking a Director of Corporate Affairs - Media Relations to be based at our corporate campus located in Thousand Oaks, California. The Director will report directly to the Executive Director of Corporate Affairs - Media Relations.

The Director of Corporate Affairs - Media Relations will be responsible for building media strategies and planning and placing compelling stories about Amgen's science, therapeutic areas, corporate initiatives and philanthropy to help build and protect Amgen's reputation. To achieve their goals, they will collaborate with numerous cross-functional partners to identify and deliver compelling narratives.

Key responsibilities of the Director of Corporate Affairs - Media Relations will include:
  • Builds and executes enterprise-wide media strategies
  • Coordinates with R&D, Operations, product and other Amgen communicators to build compelling media storylines, editorial and syndication calendars
  • Develops positive relationships with short and long-lead consumer outlets
  • Proactively pitches targeted stories to generate favorable press coverage with business, health, trade and consumer press and long-lead coverage spanning a variety of topics of key importance to Amgen
  • Anticipates and dedicatedly prepares company spokespeople and third-party spokespersons (where appropriate) for issues or events; including media training spokespeople
  • Coordinates interviews for key Amgen spokespeople
  • Builds and executes strategies to mitigate issues in the media
  • Researches and tracks media trends and emerging earned traditional and digital outlets
  • Develops training materials and standard methodologies for broader Corporate Affairs team
  • Manages and directs public relations agency partners to assure maximum impact and assistance in reaching desired communications goals and objectives

Basic Qualifications:

Doctorate degree and 4 years of Corporate Affairs experience


Master's degree and 7 years of Corporate Affairs experience


Bachelor's degree and 9 years of Corporate Affairs experience

Preferred Qualifications:
  • 10+ years of related experience and/or 7+ years in Biopharma communication
  • Bachelor's Degree in public relations, communication or journalism
  • 5+ years of media / journalist experience in maintaining relationships, ability to pitch and highly effective at identifying "big picture" stories that are of interest to top-tier publications
  • Experience working in-house on the communication activities of a major biotech or pharma company, including in support of the Operations organization
  • Ability to interface and influence behaviors and outcomes at all levels, including Senior Executives
  • Proven experience developing/implementing strategic communication plans with foresight in anticipating and solving complex communication issues
  • Superior verbal and writing communication skills including the ability to understand and translate complex R&D language
  • High emotional intelligence coupled with refined interpersonal and relationship management skills; enthusiastic, team player and self-starter; serious commitment to hard work and excellence
  • Strong project management and facilitation skills
  • Strategic thinker with ability to think quickly, analytically and creatively to accommodate a dynamic develop actionable programs that address business objectives

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.